↓ Skip to main content

Delayed tumor onset and reduced tumor growth progression after immunization with a Her-2/neu multi-peptide vaccine and IL-12 in c-neu transgenic mice

Overview of attention for article published in Breast Cancer Research and Treatment, January 2007
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

patent
3 patents
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
25 Dimensions

Readers on

mendeley
19 Mendeley
Title
Delayed tumor onset and reduced tumor growth progression after immunization with a Her-2/neu multi-peptide vaccine and IL-12 in c-neu transgenic mice
Published in
Breast Cancer Research and Treatment, January 2007
DOI 10.1007/s10549-006-9469-4
Pubmed ID
Authors

Stefan Wagner, Joanna Jasinska, Heimo Breiteneder, Michael Kundi, Hubert Pehamberger, Otto Scheiner, Christoph C. Zielinski, Ursula Wiedermann

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status Count As %
Professor 3 16%
Student > Master 3 16%
Researcher 3 16%
Other 2 11%
Student > Ph. D. Student 1 5%
Other 2 11%
Unknown 5 26%
Readers by discipline Count As %
Agricultural and Biological Sciences 5 26%
Biochemistry, Genetics and Molecular Biology 3 16%
Medicine and Dentistry 2 11%
Immunology and Microbiology 1 5%
Psychology 1 5%
Other 1 5%
Unknown 6 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 March 2023.
All research outputs
#2,563,476
of 23,504,445 outputs
Outputs from Breast Cancer Research and Treatment
#380
of 4,730 outputs
Outputs of similar age
#9,110
of 159,769 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#3
of 32 outputs
Altmetric has tracked 23,504,445 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,730 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 159,769 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.